NDC 78206-145

Nexplanon

Etonogestrel

Nexplanon is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Etonogestrel.

Product ID78206-145_44380976-bcdb-469e-b215-395ed322f72c
NDC78206-145
Product TypeHuman Prescription Drug
Proprietary NameNexplanon
Generic NameEtonogestrel
Dosage FormImplant
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2021-06-01
Marketing CategoryNDA /
Application NumberNDA021529
Labeler NameOrganon LLC
Substance NameETONOGESTREL
Active Ingredient Strength68 mg/1
Pharm ClassesProgesterone Congeners [CS],Progestin [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 78206-145-01

1 BLISTER PACK in 1 CARTON (78206-145-01) > 1 IMPLANT in 1 BLISTER PACK
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nexplanon" or generic name "Etonogestrel"

NDCBrand NameGeneric Name
0052-4330Nexplanonetonogestrel
78206-145Nexplanonetonogestrel
0052-0272IMPLANONetonogestrel

Trademark Results [Nexplanon]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NEXPLANON
NEXPLANON
79028211 3362650 Live/Registered
MERCK SHARP & DOHME B.V.
2006-05-04

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.